BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10968906)

  • 1. Conceptions and misconceptions in testing for lupus anticoagulants.
    Exner T
    J Autoimmun; 2000 Sep; 15(2):179-83. PubMed ID: 10968906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a modified procedure for Staclot LA for the confirmation of lupus anticoagulants.
    Charles LA; McGlasson DL; Hawksworth BA; Ashcraft JH; Ortel TL
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):601-4. PubMed ID: 7841317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory identification of lupus anticoagulants.
    Smock KJ; Rodgers GM
    Am J Hematol; 2009 Jul; 84(7):440-2. PubMed ID: 19384933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants.
    Moore GW; Smith MP; Savidge GF
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):307-12. PubMed ID: 12695757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests.
    Zhang L; Whitis JG; Embry MB; Hollensead SC
    Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved method for lupus anticoagulant detection.
    Alonso I; Vandermijnsbrugge F; Vanremoortele E; Bradstreet C; Efira A; Cantinieaux B
    Haematologica; 2005 Apr; 90(4):564-5. PubMed ID: 15820959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of subcutaneous administration of dalteparin on lupus anticoagulant assays.
    Liestøl S; Wisløff F
    Thromb Res; 2005; 115(6):509-17. PubMed ID: 15792683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection].
    Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y
    Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
    Exner T; Low J
    Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory identification of lupus anticoagulants.
    Kershaw G; Suresh S; Orellana D; Nguy YM
    Semin Thromb Hemost; 2012 Jun; 38(4):375-84. PubMed ID: 22573409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance.
    Ragland BD; Reed CE; Eiland BM; Tichenor PH; Hudson CL; Fritsma GA; Adler BK; Marques MB
    Am J Clin Pathol; 2003 Jan; 119(1):66-71. PubMed ID: 12520699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Textarin/Ecarin ratio: a confirmatory test for lupus anticoagulants.
    Triplett DA; Stocker KF; Unger GA; Barna LK
    Thromb Haemost; 1993 Dec; 70(6):925-31. PubMed ID: 8165613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Activated Seven Lupus Anticoagulant (ASLA) test has comparable sensitivity to classical assays for screening of lupus anticoagulant.
    Marinuzzo M; Adamczuk Y; Varela ML; Pombo G; Forastiero R
    Thromb Haemost; 2005 May; 93(5):1007-9. PubMed ID: 15900652
    [No Abstract]   [Full Text] [Related]  

  • 17. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices.
    Moffat KA; Ledford-Kraemer MR; Plumhoff EA; McKay H; Nichols WL; Meijer P; Hayward CP
    Thromb Haemost; 2009 Jan; 101(1):178-84. PubMed ID: 19132206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there evidence for persistent or transient positive lupus anticoagulants according to the degree of prolongation of clotting tests?
    Devreese KM
    Thromb Res; 2008; 122(4):576-9. PubMed ID: 18304615
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory diagnosis of lupus anticoagulants--effect of residual platelets in plasma, assessed by Staclot LA and silica clotting time.
    Chantarangkul V; Tripodi A; Clerici M; Bressi C; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):854-8. PubMed ID: 12038789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory testing for lupus anticoagulants: diagnostic criteria and use of screening, mixing, and confirmatory studies.
    Tripodi A
    Semin Thromb Hemost; 2008 Jun; 34(4):373-9. PubMed ID: 18814071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.